Malaria Vaccine Market Share, Size, Key Players and Forecast to 2022-2027

The latest research study “Malaria Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global malaria vaccine market size is expected to exhibit a CAGR of around 34% during 2022-2030.

Malaria refers to a disease usually caused by the plasmodium parasite that is transmitted to the human body from the bite of infected mosquitoes. Some of the common symptoms include fatigue, nausea, fever, headaches, chills, etc. The malaria vaccine represents a biological component that stimulates the production of antibodies to mitigate the risk of contracting malaria and it can be administered in various ways, such as subcutaneous, intramuscular, and intradermal injections and these vaccines can be widely categorized into an erythrocytic vaccine, a pre-erythrocytic vaccine, and a multi-antigen vaccine.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a Free PDF Sample for more detailed market insights:

Malaria Vaccine Market Trends and Drivers:

The growing prevalence of malaria, particularly across tropical countries, is primarily driving the malaria vaccine market. Additionally, the launch of favorable policies by government bodies to spread awareness regarding disease prevention, as well as the importance of immunization among consumers, especially in the endemic and rural regions, is further catalyzing the market growth. Besides this, the inflating popularity of pre-erythrocytic vaccines, also known as anti-infective vaccines, that target the plasmodium parasite and prevent progression to chronic blood-stage diseases is acting as another significant growth-inducing factor.

Moreover, numerous pharmaceutical companies are focusing on the development of improved and novel malaria vaccines by increasing the clinical trials of several pipeline drugs, which is positively influencing the global market. Apart from this, continuous technological advancements, such as the introduction of novel adjuvants and cutting-edge delivery platforms, extensive R&D activities, and the increasing investments in healthcare infrastructures, are anticipated to fuel the malaria vaccine market over the forecasted period.

Read More: Liposuction Vs. Tummy Tuck: Which Is Right For Me?

Malaria Vaccine Market Report Segmentation:


  • Pre-Erythrocytic Vaccine
  • Erythrocytic Vaccine
  • Multi-Antigen Vaccine
  • Others


  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Anopheles Species

Route of Administration:

  • Intramuscular
  • Subcutaneous
  • Intradermal
  • Others

Distribution Channel:

  • NGO/Non-Profit Organization
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others


  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Also Read: Which is the best time for 3d 4d ultrasound for the mothers?

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button